PubMed=14657947; DOI=10.1038/modpathol.3800038
Jiang S.-X., Kameya T., Asamura H., Umezawa A., Sato Y., Shinada J., Kawakubo Y., Igarashi T., Nagai K., Okayasu I.
hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors.
Mod. Pathol. 17:222-229(2004)

PubMed=20082272; DOI=10.1177/172460080902400411
Matsumoto T., Kawashima Y., Nagashio R., Kageyama T., Kodera Y., Jiang S.-X., Okayasu I., Kameya T., Sato Y.
A new possible lung cancer marker: VGF detection from the conditioned medium of pulmonary large cell neuroendocrine carcinoma-derived cells using secretome analysis.
Int. J. Biol. Markers 24:282-285(2009)

PubMed=22439015; DOI=10.1371/journal.pone.0033952; PMCID=PMC3306309
Kobayashi M., Matsumoto T., Ryuge S., Yanagita K., Nagashio R., Kawakami Y., Goshima N., Jiang S.-X., Saegusa M., Iyoda A., Satoh Y., Masuda N., Sato Y.
CAXII is a sero-diagnostic marker for lung cancer.
PLoS ONE 7:e33952.1-e33952.9(2012)

PubMed=25826333; DOI=10.1371/journal.pone.0121460; PMCID=PMC4380450
Katono K., Sato Y., Jiang S.-X., Kobayashi M., Nagashio R., Ryuge S., Fukuda E., Goshima N., Satoh Y., Saegusa M., Masuda N.
Prognostic significance of MYH9 expression in resected non-small cell lung cancer.
PLoS ONE 10:e0121460.1-e0121460.14(2015)

PubMed=29751934; DOI=10.1016/j.ajpath.2018.03.007
Yanagita K., Nagashio R., Jiang S.-X., Kuchitsu Y., Hachimura K., Ichinoe M., Igawa S., Fukuda E., Goshima N., Satoh Y., Murakumo Y., Saegusa M., Sato Y.
Cytoskeleton-associated protein 4 is a novel serodiagnostic marker for lung cancer.
Am. J. Pathol. 188:1328-1333(2018)